Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Kinase Inhibitors | 5 | 2020 | 159 | 1.830 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 3 | 2018 | 3 | 1.430 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1420 | 0.920 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2018 | 122 | 0.790 |
Why?
|
| Transferases | 1 | 2020 | 13 | 0.670 |
Why?
|
| Aryldialkylphosphatase | 2 | 2010 | 14 | 0.650 |
Why?
|
| Drug Combinations | 1 | 2020 | 102 | 0.640 |
Why?
|
| Drug Discovery | 3 | 2018 | 106 | 0.580 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 64 | 0.540 |
Why?
|
| Coumarins | 1 | 2018 | 43 | 0.530 |
Why?
|
| Pyridazines | 1 | 2015 | 16 | 0.470 |
Why?
|
| High-Throughput Screening Assays | 2 | 2012 | 72 | 0.450 |
Why?
|
| Imidazoles | 1 | 2015 | 138 | 0.440 |
Why?
|
| Aniline Compounds | 1 | 2014 | 27 | 0.430 |
Why?
|
| Nitriles | 1 | 2014 | 78 | 0.420 |
Why?
|
| Thiazoles | 1 | 2014 | 76 | 0.410 |
Why?
|
| Quinolines | 1 | 2014 | 76 | 0.410 |
Why?
|
| Camptothecin | 2 | 2014 | 24 | 0.400 |
Why?
|
| Pyrimidines | 1 | 2014 | 130 | 0.400 |
Why?
|
| Enzyme Assays | 1 | 2012 | 13 | 0.390 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 83 | 0.380 |
Why?
|
| Glucuronidase | 1 | 2012 | 21 | 0.380 |
Why?
|
| Methyltransferases | 2 | 2009 | 66 | 0.330 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 457 | 0.320 |
Why?
|
| Escherichia coli | 1 | 2012 | 461 | 0.300 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2010 | 184 | 0.300 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 979 | 0.300 |
Why?
|
| Enzymes | 1 | 2009 | 34 | 0.300 |
Why?
|
| Biological Assay | 1 | 2009 | 63 | 0.290 |
Why?
|
| Estradiol | 1 | 2010 | 269 | 0.280 |
Why?
|
| Fluorescence Polarization Immunoassay | 1 | 2007 | 1 | 0.280 |
Why?
|
| S-Adenosylmethionine | 1 | 2007 | 40 | 0.270 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 2598 | 0.230 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2015 | 98 | 0.210 |
Why?
|
| Amoxapine | 2 | 2014 | 3 | 0.210 |
Why?
|
| Humans | 8 | 2020 | 42163 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2015 | 973 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 339 | 0.170 |
Why?
|
| Pyrimidinones | 1 | 2020 | 12 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 30 | 0.160 |
Why?
|
| src-Family Kinases | 1 | 2020 | 50 | 0.160 |
Why?
|
| Pyridones | 1 | 2020 | 50 | 0.160 |
Why?
|
| RNA Interference | 1 | 2020 | 246 | 0.150 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 149 | 0.150 |
Why?
|
| Female | 5 | 2020 | 24018 | 0.130 |
Why?
|
| Cell Movement | 1 | 2020 | 640 | 0.130 |
Why?
|
| Animals | 4 | 2020 | 16695 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 273 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 933 | 0.110 |
Why?
|
| Protective Agents | 1 | 2014 | 26 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 1112 | 0.110 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2014 | 134 | 0.110 |
Why?
|
| Cells, Cultured | 1 | 2018 | 1617 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2014 | 151 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2014 | 127 | 0.100 |
Why?
|
| Isocarboxazid | 1 | 2012 | 1 | 0.100 |
Why?
|
| Nialamide | 1 | 2012 | 1 | 0.100 |
Why?
|
| Phenelzine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mefloquine | 1 | 2012 | 4 | 0.100 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2012 | 27 | 0.090 |
Why?
|
| Mice | 2 | 2020 | 6490 | 0.090 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 133 | 0.080 |
Why?
|
| Cell Survival | 1 | 2014 | 934 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2010 | 35 | 0.080 |
Why?
|
| Umbelliferones | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hydroxyquinolines | 1 | 2010 | 2 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 182 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2009 | 36 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 100 | 0.070 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2007 | 11 | 0.070 |
Why?
|
| Benzophenones | 1 | 2007 | 10 | 0.070 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2007 | 18 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 884 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 534 | 0.070 |
Why?
|
| Sex Factors | 1 | 2010 | 1008 | 0.060 |
Why?
|
| Cell Line | 1 | 2010 | 1416 | 0.060 |
Why?
|
| Rats | 1 | 2010 | 3701 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2014 | 157 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 462 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 183 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Male | 1 | 2010 | 22779 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1554 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 1341 | 0.010 |
Why?
|